-
1
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
Published 2019-05-01Subjects: “…alkylating agents…”
Get full text
Article -
2
-
3
Revisiting ABC Transporters and Their Clinical Significance in Glioblastoma
Published 2025-01-01Subjects: Get full text
Article -
4
In Vivo Evidence of Melatonin’s Protective Role in Alkylating-Agent-Induced Pulmonary Toxicity: A Systematic Review
Published 2025-06-01Subjects: Get full text
Article -
5
Second primary malignancies in cancer survivors: epidemiology, role of anticancer therapy
Published 2016-09-01Subjects: Get full text
Article -
6
Loss of p21 does not protect against premature ovarian insufficiency caused by alkylating agents
Published 2025-07-01Subjects: Get full text
Article -
7
Comparative safety analysis of bevacizumab and alkylating agent in glioblastoma management – What have we learned recently?
Published 2025-05-01Subjects: Get full text
Article -
8
Cyclophosphamide: An Overview
Published 2025-01-01Subjects: “…alkylating agent…”
Get full text
Article -
9
Second primary malignancies of cancer patients: treatment-related carcinogenesis
Published 2016-09-01Subjects: Get full text
Article -
10
Vasotoxic Effects of Anticancer Therapy: a Review of Current Data
Published 2023-05-01Subjects: Get full text
Article